Shandong Provincial Hospital
244
56
66
43
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
2.5%
6 terminated/withdrawn out of 244 trials
87.8%
+1.3% vs industry average
22%
54 trials in Phase 3/4
0%
0 of 43 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (244)
Laparoscopic Staging for Stage III Gastric Cancer
Role: collaborator
Cardiac Magnetic Resonance-Clinical Prediction Model-Dilated Cardiomyopathy
Role: lead
Blood mNGS for Diagnosing Invasive Pulmonary Fungal Disease in Hematologic Patients
Role: collaborator
Observational Study on Dynamic Changes of Blood Pressure During Post-epileptic Seizure Stage (OCBPS)
Role: collaborator
Optimizing Endoscopic and Interventional Treatment for Portal Hypertensive Bleeding
Role: collaborator
Chronic Kidney Disease and Metabolic Disorders in the Elderly
Role: collaborator
China Cognition and Aging Study
Role: collaborator
The Ketogenic Diet in the Treatment of Alzheimer's Disease
Role: collaborator
The Chinese Familial Alzheimer's Network
Role: collaborator
The Effect of PPI on Endoscopic Treatment of WON: a Multicenter Randomized Controlled Trial.
Role: collaborator
The Diagnostic Cut-off Value of Core Biomarkers of Alzheimer's Disease
Role: collaborator
Detection of Alzheimer's Disease (AD)-Related Seeds for AD Diagnosis
Role: collaborator
IABP for MI-VSD Patients in SCAI SHOCK Stage B
Role: collaborator
New Double Epigenetic Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Role: collaborator
Omitting Nasogastric Tube Decompression in Minimally Invasive Pancreaticoduodenectomy
Role: collaborator
Blood Purification in Septic Children
Role: collaborator
AN69ST Verse PS in CBP in Septic Children
Role: collaborator
An Artificial Intelligence System for Multimodal, Multi-class Diagnosing Solid Pancreatic Lesions Based on Endoscopic Ultrasound
Role: collaborator
Evaluation of Postoperative Adjuvant Chemotherapy Efficacy for Bladder Cancer Based on Organoid Technology.
Role: collaborator
Evaluating the Efficacy of Neoadjuvant Chemotherapy Drugs Based on Organoid Technology
Role: collaborator